Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

SJ Webster, AD Bachstetter, PT Nelson… - Frontiers in …, 2014 - frontiersin.org
The goal of this review is to discuss how behavioral tests in mice relate to the pathological
and neuropsychological features seen in human Alzheimer's disease (AD), and present a …

APP processing in Alzheimer's disease

Y Zhang, R Thompson, H Zhang, H Xu - Molecular brain, 2011 - Springer
An important pathological feature of Alzheimer's disease (AD) is the presence of
extracellular senile plaques in the brain. Senile plaques are composed of aggregations of …

Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin

E Zenaro, E Pietronigro, VD Bianca, G Piacentino… - Nature medicine, 2015 - nature.com
Inflammation is a pathological hallmark of Alzheimer's disease, and innate immune cells
have been shown to contribute to disease pathogenesis. In two transgenic models of …

Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis

Q Liu, Y Xi, Q Wang, J Liu, P Li, X Meng, K Liu… - Brain, Behavior, and …, 2021 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
cognitive deficits and psychiatric symptoms. The gut microbiota-brain axis plays a pivotal …

[PDF][PDF] Benzodiazepine use and risk of Alzheimer's disease: case-control study

SB De Gage, Y Moride, T Ducruet, T Kurth, H Verdoux… - Bmj, 2014 - bmj.com
Objectives To investigate the relation between the risk of Alzheimer's disease and exposure
to benzodiazepines started at least five years before, considering both the dose-response …

Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology

F Kosel, JMS Pelley, TB Franklin - Neuroscience & Biobehavioral Reviews, 2020 - Elsevier
Transgenic mouse models have been used extensively to model the cognitive impairments
arising from Alzheimer's disease (AD)-related pathology. However, less is known about the …

A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease

Y Kashiwaya, C Bergman, JH Lee, R Wan, MT King… - Neurobiology of …, 2013 - Elsevier
Alzheimer's disease (AD) involves progressive accumulation of amyloid β-peptide (Aβ) and
neurofibrillary pathologies, and glucose hypometabolism in brain regions critical for …

50 years of hurdles and hope in anxiolytic drug discovery

G Griebel, A Holmes - Nature reviews Drug discovery, 2013 - nature.com
Anxiety disorders are the most prevalent group of psychiatric diseases, and have high
personal and societal costs. The search for novel pharmacological treatments for these …

Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer's disease

GK Gouras, D Tampellini, RH Takahashi… - Acta …, 2010 - Springer
The aberrant accumulation of aggregated β-amyloid peptides (Aβ) as plaques is a hallmark
of Alzheimer's disease (AD) neuropathology and reduction of Aβ has become a leading …

The age of anxiety: role of animal models of anxiolytic action in drug discovery

JF Cryan, FF Sweeney - British journal of pharmacology, 2011 - Wiley Online Library
Anxiety disorders are common, serious and a growing health problem worldwide. However,
the causative factors, aetiology and underlying mechanisms of anxiety disorders, as for most …